VYNE Therapeutics Announces Formation of Scientific Advisory Board
Renowned Experts to Support VYNE’s Strategy of Developing Novel Treatments for Immunological and Inflammatory diseases SAB to Help Guide Clinical...
Day: October 21, 2021
Adagene to Participate in the Jefferies Virtual China Biotech Summit
SAN FRANCISCO and SUZHOU, China, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical...
BioDelivery Sciences Appoints John Golubieski as Chief Financial Officer
RALEIGH, N.C., Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company...
Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder
Lead candidate SPL026 granted MHRA Innovation Passport DesignationLONDON, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB:...
Nephros Announces Third Quarter 2021 Financial Results Conference Call
SOUTH ORANGE, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration...
Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on...
Arbutus to Report Third Quarter 2021 Financial Results and Provide Corporate Update
WARMINSTER, Pa., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
OpGen Subsidiary Ares Genetics Launches AREScloud
AREScloud is a new, commercial web application aimed at accelerating the analysis of sequenced clinical isolatesAREScloud offers an advanced solution...
Abeona Therapeutics to Present at Jefferies Gene Therapy/Editing Summit
NEW YORK and CLEVELAND, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene...
Jushi Holdings Inc. Secures US$100 Million Acquisition Facility from Sunstream
New Debt Facility to Offer Capital to Accelerate US Expansion Strategy in Core and Target MarketsBOCA RATON, Fla., Oct. 21,...
First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis
Committee members include globally renowned experts in medical oncology, immune checkpoint inhibitor therapeutics, gastrointestinal (GI) diseases and cancer immunotherapy-related GI...
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
SAN CARLOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. a company focused on developing cellular and cell derived...
PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination
Temporary administrative suspension of recruitment – no safety or efficacy concerns related specifically to the novel PDS0101-based combination studyFLORHAM PARK,...
The Joint Corp. to Host Conference Call on Thursday, November 4th to Discuss Third Quarter 2021 Results
SCOTTSDALE, Ariz., Oct. 21, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care...
Matinas BioPharma Initiates Dosing in Phase 1 Study of Potential First Oral Aminoglycoside Antibiotic Drug MAT2501
– Phase 1 study of oral amikacin in healthy volunteers expected to complete in Q1 2022 –BEDMINSTER, N.J., Oct. 21,...
Evelo Biosciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines...
Linneo Health announces GMP certification of quality control laboratory by AEMPS
Linneo Health announces GMP certification of quality control laboratory by AEMPS Company holds one of the most advanced cannabis quality...
reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase
Press release reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in...
CBD of Denver Comments on Progress of Cannabis Legalization Efforts in Switzerland
Denver, Colorado--(Newsfile Corp. - October 21, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp...
VIVO Cannabis(TM) Completes First Shipment of EU-GMP Medical Grade Cannabis to Beacon Medical Germany GmbH
Toronto, Ontario--(Newsfile Corp. - October 21, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading...
